A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules

Clinical trial NCT02531204 · COMPLETED

Trial details

NCT number: NCT02531204
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Urine Phosphorus Excretion

Start date: 2014-08-01
Primary completion: 2015-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.